U S Department of Health and Human Services www.hhs.gov
  CMS Home > Medicare > Medicare Coverage - General Information > Medicare Coverage Database > Indexes Home > Coding Analyses for Labs (CALs)

Medicare Coverage Database

Coding Analyses for Labs (CALs)


     Go to National Coverage Analyses (NCAs)

 Open(Go to Closed)

  • There are no items for this list.
    •


       Go to National Coverage Analyses (NCAs)

     Closed(Go to Open)

    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

    There are 35 items in this list.
  • Blood Counts (Addition of ICD-9-CM Codes V77.1, V81.0, V81.1, and V81.2 to the list of Codes that Do Not Support Medical Necessity)
  • Blood Counts (Revision of CPT Codes)
  • Blood Glucose Testing (Revision of ICD-9-CM Codes for Osteomyelitis)
  • Codes That Are Not Covered by Medicare (Removal of ICD-9-CM Code V76.44, Prostate Cancer Screening, From the List)
  • Coding Guidelines for Urine Culture
  • Glycated Hemoglobin/Glycated Protein (Addition of CPT Code 83037, Hemoglobin; glycosylated [A1c] by device cleared by FDA for home use)
  • Glycated Hemoglobin/Glycated Protein (Addition of ICD-9-CM 271.3, Intestinal disaccharidase deficiencies and disaccharide malabsorption)
  • Hepatitis Panel (Removal of ICD-9-CM Code 784.69, Other symbolic dysfunction, from the list of Codes Covered by Medicare)
  • Hepatitis Panel/Acute Hepatitis Pane (Addition of ICD-9-CM 790.4, Elevation of Levels of Transaminase or Lactic Acid Dehydrogenase)
  • Hepatitis Panel/Acute Hepatitis Panel (Addition of ICD-9-CM 790.5, Other nonspecific abnormal serum enzyme levels, as a covered indication)
  • Human Chorionic Gonadotropin (Addition of ICD-9-CM Code 158.9, Malignant Neoplasm of Peritoneum, Unspecified)
  • Lipid and Blood Glucose Testing (Modification of Code List to Implement Screening Benefit Added by Medicare Modernization Act (MMA)
  • Partial Thromboplastin Time (Addition of ICD-9-CM 289.81, Primary Hypercoagulable State as a covered indication)
  • Partial Thromboplastin Time (PTT) (Addition of ICD-9-CM V58.83, Encounter for therapeutic drug monitoring, as a covered indication)
  • Prostate Specific Antigen (Addition of ICD-9-CM 600.00, Hypertrophy (benign) of Prostate Without Urinary Obstruction, as a covered indication)
  • Prostate Specific Antigen (Inclusion of ICD-9-CM Code 600.01 for BPH with Urine Obstruction)
  • Prothrombin Time (Addition of ICD-9-CM 289.81, Primary Hypercoagulable State as a Covered Indication)
  • Prothrombin Time (PT) (Addition of ICD-9-CM V58.83, Encounter for therapeutic drug monitoring, as a covered indication)
  • Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) tests (Removal of Unspecified Joint Replacements)
  • Prothrombin Time and Fecal Occult Blood (Revision of ICD-9-CM Codes for Injury to Gastrointestinal Tract)
  • Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Pre-operative Examinations)
  • Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Swelling of Limb)
  • PSA (Addition of ICD-9-CM 600.10, Nodular prostate without urinary obstruction and 600.11, with urinary obstruction, as covered indications)
  • PSA (Addition of ICD-9-CM 600.21, Benign localized hyperplasia of prostate with urinary obstruction as a covered indication)
  • Removal of ICD-9-CM Code V76.51, Special Screening for Malignant Neoplasms of Colon, From the List of Codes Never Covered by Medicare
  • Serum Iron Studies (Expansion of the Chronic Renal Failure Covered Codes to Include Hypertensive Renal Disease)
  • Serum Iron Studies for Anemia Caused by Sickle Cell or End Stage Renal Disease
  • Stem Cell Transplantation (Removal of Coding Information from NCD)
  • Thyroid Testing (Addition of ICD-9-CM 783.0, Anorexia, as a covered indication)
  • Thyroid Testing (Inclusion of ICD-9-CM Code 733.02 for Idiopathic Osteoporosis)
  • Tumor Antigen by Immunoassay CA 125 (Modification of Code List to Include ICD-9-CM Codes for Suspicious Ovarian Mass)
  • Tumor Antigen by Immunoassay CA 19-9 (Modification of Code List to Include ICD-9-CM Code 156.2, Malignant neoplasm of Ampulla of Vater)
  • Tumor Antigen Immunoassay CA 125 (Revision to Include Additional Personal History of Malignancy Codes)
  • Urine Culture (Bacterial) and Serum Iron Studies (Revision of ICD-9-CM Codes for Pre-operative Examinations)
  • Urine Culture Bacterial (Re-evaluation of Inclusion of Renal Failure in the List of ICD-9-CM Codes Covered)
    •


    Page Last Modified: 5/30/2008 4:06:12 PM

    Help with File Formats and Plug-Ins

    Submit Feedback





    www3